NCT01629511 2020-02-24Allogeneic Stem Cell Transplant for CLLM.D. Anderson Cancer CenterPhase 1/2 Terminated15 enrolled 12 charts
NCT01408043 2019-06-14Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin LymphomaCase Comprehensive Cancer CenterPhase NA Terminated25 enrolled 15 charts
NCT00012298 2018-08-09Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1/2 Terminated81 enrolled 16 charts
NCT00281879 2017-09-27Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerOHSU Knight Cancer InstitutePhase 2 Terminated200 enrolled 11 charts
NCT01076270 2017-06-28Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesFred Hutchinson Cancer CenterPhase NA Terminated1 enrolled 7 charts